Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Revenue (2019 - 2023)

Historic Revenue for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to $7000.0.

  • Benitec Biopharma's Revenue changed N/A to $7000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was $7000.0, marking a year-over-year decrease of 8970.59%. This contributed to the annual value of $75000.0 for FY2023, which is 273.97% up from last year.
  • Per Benitec Biopharma's latest filing, its Revenue stood at $7000.0 for Q2 2023.
  • In the past 5 years, Benitec Biopharma's Revenue registered a high of $77000.0 during Q4 2019, and its lowest value of -$35000.0 during Q2 2020.
  • In the last 5 years, Benitec Biopharma's Revenue had a median value of $25000.0 in 2021 and averaged $23846.2.
  • In the last 5 years, Benitec Biopharma's Revenue crashed by 9870.13% in 2020 and then soared by 470000.0% in 2022.
  • Over the past 5 years, Benitec Biopharma's Revenue (Quarter) stood at $77000.0 in 2019, then tumbled by 98.7% to $1000.0 in 2020, then soared by 2400.0% to $25000.0 in 2021, then plummeted by 44.0% to $14000.0 in 2022, then crashed by 50.0% to $7000.0 in 2023.
  • Its Revenue stands at $7000.0 for Q2 2023, versus $54000.0 for Q1 2023 and $14000.0 for Q4 2022.